O

Orlando Health

Not-for-profit healthcare system serving the Southeast

Registered Nurse Chemotherapy Infusion Oncology

Full-TimeDeadline 10/8/27
No salary listed
Mid
Bachelor's, Associate's
Orlando, FL, USA
In PersonLocated at Dr. Phillips.
Medical, Clinical & VeterinaryNursing & Frontline Patient Care

About the job

Requirements
  • At least 2 years of oncology nursing experience.
  • An Associate degree or Diploma in Registered Nursing is required.
  • A current Florida Registered Nurse license must be maintained.
  • An active Oncology Nurse Certification (OCN) for adult oncology or Certified Pediatric Hematology/Oncology Nurse (CPHON) for pediatrics is required.
  • Current Basic Life Support (BLS) certification is required.
  • Proficiency in managing central lines, invasive medical devices, and infection protocols is required.
  • Completion of the required Orlando Health Oncology Chemotherapy/Biotherapy/Immunotherapy Verification Courses and a 90-day orientation with a verified Oncology Preceptor is required.
Responsibilities
  • Coordinate outpatient care and act as a liaison between the provider, family, and office team.
  • Perform patient assessments, provide symptom management, and educate patients and families.
  • Set up and administer chemotherapy, fluids, and other medications via venous access while consistently following the five rights.
  • Safely administer chemotherapy/biotherapy, infusions, injections, and transfusions.
  • Perform chemotherapy dose checks and monitor laboratory values for administration.
  • Perform phlebotomy blood draws.
  • Monitor chemotherapy and medication side effects and recognize potential drug interactions.
  • Access central catheters, including ports and peripherally inserted central catheters (PICCs).
  • Work as part of a multidisciplinary team to provide continuity of care throughout treatment and follow-up, collaborating with providers, social work, dietitians, integrative medicine, pharmacy, navigators, laboratory, radiation therapy, genetics, and clinical research.
  • Educate patients about chemotherapy, laboratory tests, procedures, symptoms, medications, and other information as needed.
  • Review incoming laboratory, imaging, and procedure results and forward abnormal results to providers.
  • Triage patients using pathways and collaborate with physicians on toxicities, symptom management, and referrals within the registered nurse scope of practice.
  • Manage an outpatient caseload of patients receiving a variety of infusion and oral therapies.
  • Flex between inpatient and outpatient areas to administer chemotherapy based on department and patient needs.
  • Manage a complex workload to provide safe, high-quality care.
  • Communicate through various methods and with various audiences to achieve desired outcomes.
  • Participate in continuous professional development, safety behaviors, and efforts focused on the patient experience.
  • Meet ongoing visual and reading demands to assess patient needs, read labels and information, operate monitors, and identify equipment and supplies.
  • Verbally communicate with and hear and understand information from care providers, patients, and visitors, including alarms and issues quickly and accurately during emergencies.
  • Apply risk management concepts.
  • Maintain awareness of legal issues, patient rights, and regulatory and accrediting standards.
  • Participate in formal and informal educational programming.
  • Provide ongoing training for team members, including orientation and in-services.
  • Investigate complaints or policy non-compliance and initiate follow-up actions as warranted.
  • Participate in corporate, task force, and community committees.
Desired Qualifications
  • A Bachelor of Science in Nursing is preferred.

About the company

Orlando Health is a not-for-profit healthcare system that runs hospitals, clinics, and other health services in the southeastern United States. It coordinates care through its network of facilities and clinicians, combining inpatient and outpatient services to provide medical treatment and preventive care. It stands out from competitors by being not-for-profit, with a long history and a regional focus that allows reinvesting earnings into local health initiatives rather than distributing profits to shareholders. Its goal is to improve community health by delivering high-quality, accessible care and using surplus funds to expand services and support community benefits.

Company Size

N/A

Company Stage

N/A

Total Funding

$250.5M

Headquarters

Orlando, Florida

Founded

1918

Get referred to Orlando Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • RMC Health System acquisition adds 375 beds and 2,000 employees in Alabama.
  • Orlando Health Watson Clinic Lakeland Highlands Hospital opens in June 2026.
  • Institute Square opened in St. Petersburg with Florida Cancer Specialists and on-site PET/CT.

What critics are saying

  • Fiscal 2025 operating margin fell to 3.5% after acquisition-driven expense growth.
  • The Rockledge closure triggered 900 layoffs and demolition plans across Brevard County.
  • Website-tracking litigation signaled class-action exposure across Orlando Health's digital front door.

What makes Orlando Health unique

  • Orlando Health built a $10 billion multi-state system through aggressive hospital acquisitions.
  • Its Institute Square combines cancer, orthopedics, and women’s care under one campus.
  • Watson Clinic and FCS partnerships deepen physician alignment without full mergers.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Student Loan Assistance
  • Tuition Reimbursement
  • Family Planning Benefits

Company News

PR Newswire
Feb 13th, 2026
Florida cancer centre opens 31,000 sq ft St Petersburg facility with on-site imaging

Florida Cancer Specialists & Research Institute has opened a new 31,000-square-foot facility at Orlando Health Institute Square in St. Petersburg, expanding cancer care access in Pinellas County. The location at 725 6th Ave South features 18 private exam rooms, 47 infusion chairs and on-site PET/CT imaging. The facility offers advanced treatments including bispecific therapies and clinical trial participation, with plans to expand outpatient cell therapy programmes. Six board-certified medical oncologists and haematologists, supported by four advanced practice practitioners, provide care through a collaborative, patient-centred model. The opening represents a hospital-specialty collaboration aimed at bringing complex therapies closer to patients' homes. FCS operates six other locations in Pinellas County and has delivered oncology care in Florida for over 40 years.

Business Wire
Nov 3rd, 2025
Quanta Raises $245 Million to Accelerate Commercialization of its SC+ Portable Hemodialysis System

Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a medical technology leader delivering on its vision for more flexible and accessible dialysis ...

RY Orthopedics
Aug 18th, 2025
Orthopedic Driven Imaging secures new strategic funding from the Innovation Center at Orlando Health Jewett Orthopedic Institute to advance the patient-specific surgery ecosystem - Orthopedics This Week

Gainesville, FL – 8/18/2025 – Orthopedic Driven Imaging (ODI), a medical technology company building the next generation of orthopedic imaging solutions, announced today a strategic investment from the Innovation Center at Orlando Health Jewett Orthopedic Institute. The investment supports ODI’s mission to simplify surgery and improve outcomes through a unique ecosystem of imaging hardware and […]

CBS 42
Aug 5th, 2024
Florida company to buy majority interest in Brookwood Baptist Health

BIRMINGHAM, Ala. (WIAT) — Orlando Health, Inc. has signed an agreement to purchase majority interest in Brookwood Baptist Health. According to a news release from Orlando Health, they will ma…

Business Wire
Jun 9th, 2023
BioStable Science & Engineering Announces Initial Closing of Series C Equity Round

BioStable Science & Engineering announces the initial closing of its Series C financing